ジョージア州における膵臓がんの臨床試験
ジョージア州内の拠点で、膵臓がんに関する26件の研究が参加者を募集しています。
ジョージア州内の都市
公式研究テキスト（英語）
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Emory University, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Piedmont Cancer Institute, Atlanta
- Piedmont Healthcare, Atlanta
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- Emory University Hospital/Winship Cancer Institute, Atlanta
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06423326Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Piedmont Healthcare, Atlanta
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07621718A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University Cancer & Blood Center, LLC, Athens
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Piedmont Physicians Medical Oncology Atlanta, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07252232A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Piedmont Healthcare - Piedmont Physicians Medical Oncology Atlanta, Atlanta
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07409272A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US023, Atlanta
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07522073Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
- Piedmont Healthcare, Atlanta
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/21更新 · NCT06271291A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Emory University - Winship Cancer Institute, Atlanta
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- Emory University Hospital/Winship Cancer Institute, Atlanta
被験者募集中観察研究
17歳以下 · 全性別 · 2026/09/11更新 · NCT06651580A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Emory University, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
被験者募集中観察研究
50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Emory University - Winship Cancer Institute, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT06582017Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
- Emory University, Atlanta
被験者募集中
18歳〜120歳 · 全性別 · 2026/08/27更新 · NCT06698458Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Piedmont Hospital, Atlanta
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT06958328Pancreatic Cancer Early Detection Consortium
- Emory University Hospital, Atlanta
被験者募集中観察研究健康なボランティア歓迎
18歳〜90歳 · 全性別 · 2026/07/22更新 · NCT04970056Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Piedmont Healthcare Inc., Atlanta
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06937177Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06998940Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Piedmont Healthcare, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Atlanta
- Ohio State University-Telemedicine, Augusta
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- North Georgia Health System, Gainesville
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- Northside Hospital, Atlanta
- Northeast Georgia Medical Center Braselton, Braselton
- John B Amos Cancer Center, Columbus
- 他8件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/09更新 · NCT06073431SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
- Emory University Hospital/Winship Cancer Institute, Atlanta
被験者募集中観察研究
18歳以上 · 全性別 · 2025/08/01更新 · NCT06595160American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
- Augusta University, Augusta
被験者募集中観察研究
18歳以上 · 全性別 · 2025/02/25更新 · NCT02674100ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。